A phase I study of E7080, a multitargeted tyrosine kinase inhibitor, in patients with advanced solid tumours

被引：0
作者：
D S Boss
H Glen
J H Beijnen
M Keesen
R Morrison
B Tait
W Copalu
A Mazur
J Wanders
J P O'Brien
J H M Schellens
T R J Evans
机构：
[1] The Netherlands Cancer Institute,Division of Medical Oncology, Department of Clinical Pharmacology
[2] Plesmanlaan 121,Department of Pharmacy
[3] Beatson West of Scotland Cancer Centre,Department of Biomedical Analysis
[4] Slotervaart Hospital,undefined
[5] Utrecht University,undefined
[6] Eisai Europe Limited,undefined
[7] European Knowledge Centre,undefined
[8] Eisai Inc.,undefined
[9] Woodcliff Lake,undefined
[10] NJ,undefined
[11] USA,undefined
[12] Institute of Cancer Sciences,undefined
[13] University of Glasgow,undefined
来源：
British Journal of Cancer | 2012年 / 106卷
关键词：
dose escalation; E7080; pharmacokinetics; phase I; receptor tyrosine kinase inhibitor; solid tumours;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1598 / 1604
页数：6
相关论文
共 282 条
[81]  
Li S(undefined)undefined undefined undefined undefined-undefined
[82]  
Han M(undefined)undefined undefined undefined undefined-undefined
[83]  
Mao L(undefined)undefined undefined undefined undefined-undefined
[84]  
Lin X(undefined)undefined undefined undefined undefined-undefined
[85]  
Du N(undefined)undefined undefined undefined undefined-undefined
[86]  
Zhang X(undefined)undefined undefined undefined undefined-undefined
[87]  
Li J(undefined)undefined undefined undefined undefined-undefined
[88]  
Wang B(undefined)undefined undefined undefined undefined-undefined
[89]  
Qin S(undefined)undefined undefined undefined undefined-undefined
[90]  
Horstmann E(undefined)undefined undefined undefined undefined-undefined
45678910111213